by: ASRM Office of Public Affairs
Published in ASRM Bulletin, Volume 16 Number 30
The Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health has issued announcements for two new funding opportunities involving research on the long-term outcomes of assisted reproductive technologies.
These funding opportunity announcements (FOA) encourage the extramural scientific community to submit applications to study potential long-term health and developmental outcomes of Assisted Reproductive Technologies (ART) and Non-IVF Fertility Treatments (NIFT). Knowledge gained from research supported by the FOAs should answer the following questions:
- Does ART or NIFT affect the general health status of the children as they progress into young adults and during adulthood?
- Are there differences in the incidence and type of outcomes in young adults and adults born from ART and NIFT procedures?
- Do ART and NIFT lead to chronic pathological conditions such as respiratory, cardiac, ocular, metabolic or psychiatric illnesses during adolescence or in adulthood?
- What is the impact of ART and NIFT on the fertility status of the reproductive age group adults born out of ART/NIFT? Can it be correlated with the infertility/subfertility status of the parents?
- Do birth outcomes such as preterm, prematurity, low birth weight, born as singleton or multiple offspring lead to different long-term outcome in the health status? What is the impact of ART or NIFT on height and weight of the body during adolescence and in adult life?
- What is the impact of individual ART or NIFT procedure on the long-term health of offspring born out of assisted conception?
For more information about these opportunities, including eligibility requirements and application submission dates please see:
The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at email@example.com.